299 related articles for article (PubMed ID: 28806471)
1. Limited uptake of ulcerative colitis "treat-to-target" recommendations in real-world practice.
Bryant RV; Costello SP; Schoeman S; Sathananthan D; Knight E; Lau SY; Schoeman MN; Mountifield R; Tee D; Travis SPL; Andrews JM
J Gastroenterol Hepatol; 2018 Mar; 33(3):599-607. PubMed ID: 28806471
[TBL] [Abstract][Full Text] [Related]
2. Application of clinical indexes in ulcerative colitis patients in regular follow-up visit: correlation with endoscopic 'mucosal healing' and implication for management. Preliminary results.
Pagnini C; Menasci F; Festa S; Rizzatti G; Corleto VD; Delle Fave MM; D'Ambra G; Di Giulio E; Delle Fave G
Eur Rev Med Pharmacol Sci; 2015 Oct; 19(19):3674-81. PubMed ID: 26502857
[TBL] [Abstract][Full Text] [Related]
3. Adalimumab for Induction of Histological Remission in Moderately to Severely Active Ulcerative Colitis.
Fernández-Blanco JI; Fernández-Díaz G; Cara C; Vera MI; Olivares D; Taxonera C
Dig Dis Sci; 2018 Mar; 63(3):731-737. PubMed ID: 29372480
[TBL] [Abstract][Full Text] [Related]
4. Treat to target in inflammatory bowel disease: a survey of treatment strategies amongst Portuguese doctors.
Bernardo S; Fernandes SR; Araújo-Correia L
Rev Esp Enferm Dig; 2019 Aug; 111(8):593-597. PubMed ID: 31190548
[TBL] [Abstract][Full Text] [Related]
5. Real-world use of endoscopic and histological indices in ulcerative colitis: Results of a global survey.
Nardone OM; Iacucci M; Villanacci V; Peyrin-Biroulet L; Ghosh S; Danese S; Parigi TL
United European Gastroenterol J; 2023 Jul; 11(6):514-519. PubMed ID: 37323091
[TBL] [Abstract][Full Text] [Related]
6. Fecal Calprotectin in Assessing Endoscopic and Histological Remission in Patients with Ulcerative Colitis.
Mak WY; Buisson A; Andersen MJ; Lei D; Pekow J; Cohen RD; Kahn SA; Pereira B; Rubin DT
Dig Dis Sci; 2018 May; 63(5):1294-1301. PubMed ID: 29468374
[TBL] [Abstract][Full Text] [Related]
7. Treatment Targets in Inflammatory Bowel Disease: Current Status in Daily Practice.
Römkens TE; Gijsbers K; Kievit W; Hoentjen F; Drenth JP
J Gastrointestin Liver Dis; 2016 Dec; 25(4):465-471. PubMed ID: 27981302
[TBL] [Abstract][Full Text] [Related]
8. A composite disease activity index for early drug development in ulcerative colitis: development and validation of the UC-100 score.
Jairath V; Jeyarajah J; Zou G; Parker CE; Olson A; Khanna R; D'Haens GR; Sandborn WJ; Feagan BG
Lancet Gastroenterol Hepatol; 2019 Jan; 4(1):63-70. PubMed ID: 30343116
[TBL] [Abstract][Full Text] [Related]
9. Noninvasive biomarkers as surrogate predictors of clinical and endoscopic remission after infliximab induction in patients with refractory ulcerative colitis.
Hassan EA; Ramadan HK; Ismael AA; Mohamed KF; El-Attar MM; Alhelali I
Saudi J Gastroenterol; 2017; 23(4):238-245. PubMed ID: 28721978
[TBL] [Abstract][Full Text] [Related]
10. Histological healing after infliximab induction therapy in children with ulcerative colitis.
Wiernicka A; Szymanska S; Cielecka-Kuszyk J; Dadalski M; Kierkus J
World J Gastroenterol; 2015 Oct; 21(37):10654-61. PubMed ID: 26457025
[TBL] [Abstract][Full Text] [Related]
11. Defining endoscopic response and remission in ulcerative colitis clinical trials: an international consensus.
Vuitton L; Peyrin-Biroulet L; Colombel JF; Pariente B; Pineton de Chambrun G; Walsh AJ; Panes J; Travis SP; Mary JY; Marteau P
Aliment Pharmacol Ther; 2017 Mar; 45(6):801-813. PubMed ID: 28112419
[TBL] [Abstract][Full Text] [Related]
12. Differentiating ulcerative colitis from Crohn disease in children and young adults: report of a working group of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the Crohn's and Colitis Foundation of America.
; ; Bousvaros A; Antonioli DA; Colletti RB; Dubinsky MC; Glickman JN; Gold BD; Griffiths AM; Jevon GP; Higuchi LM; Hyams JS; Kirschner BS; Kugathasan S; Baldassano RN; Russo PA
J Pediatr Gastroenterol Nutr; 2007 May; 44(5):653-74. PubMed ID: 17460505
[TBL] [Abstract][Full Text] [Related]
13. Is mucosal healing more common than clinical remission in ulcerative colitis? - Is it the truth or only a myth coming from the studies?
Rutka M; Milassin Á; Szepes Z; SzŰcs M; Nyári T; Bálint A; Bor R; Molnár T; Farkas K
Scand J Gastroenterol; 2015 Aug; 50(8):985-90. PubMed ID: 25733077
[TBL] [Abstract][Full Text] [Related]
14. Predictors and outcomes of histological remission in ulcerative colitis treated to endoscopic healing.
Jangi S; Yoon H; Dulai PS; Valasek M; Boland BS; Jairath V; Feagan BG; Sandborn WJ; Singh S
Aliment Pharmacol Ther; 2020 Sep; 52(6):1008-1016. PubMed ID: 33119168
[TBL] [Abstract][Full Text] [Related]
15. Knowledge and attitudes towards the use of histological assessments in ulcerative colitis by gastroenterologists
Pudipeddi A; Fung C; Christensen B; Bryant RV; Subramaniam K; Chetwood J; Paramsothy S; Leong RW
World J Gastroenterol; 2023 Jan; 29(2):378-389. PubMed ID: 36687119
[TBL] [Abstract][Full Text] [Related]
16. Predictors of endoscopic inflammation in patients with ulcerative colitis in clinical remission.
Rosenberg L; Lawlor GO; Zenlea T; Goldsmith JD; Gifford A; Falchuk KR; Wolf JL; Cheifetz AS; Robson SC; Moss AC
Inflamm Bowel Dis; 2013; 19(4):779-84. PubMed ID: 23446338
[TBL] [Abstract][Full Text] [Related]
17. The Ulcerative Colitis Endoscopic Index of Severity is Useful to Predict Medium- to Long-Term Prognosis in Ulcerative Colitis Patients with Clinical Remission.
Arai M; Naganuma M; Sugimoto S; Kiyohara H; Ono K; Mori K; Saigusa K; Nanki K; Mutaguchi M; Mizuno S; Bessho R; Nakazato Y; Hosoe N; Matsuoka K; Inoue N; Ogata H; Iwao Y; Kanai T
J Crohns Colitis; 2016 Nov; 10(11):1303-1309. PubMed ID: 27194529
[TBL] [Abstract][Full Text] [Related]
18. Determining the optimal treatment target in patients with ulcerative colitis: rationale, design, protocol and interim analysis for the randomised controlled VERDICT trial.
Jairath V; Zou G; Wang Z; Adsul S; Colombel JF; D'Haens GR; Freire M; Moran GW; Peyrin-Biroulet L; Sandborn WJ; Sebastian S; Travis S; Vermeire S; Radulescu G; Sigler J; Hanžel J; Ma C; Sedano R; McFarlane SC; Arya N; Beaton M; Bossuyt P; Danese S; Green D; Harlan W; Horynski M; Klopocka M; Petroniene R; Silverberg MS; Wolanski L; Feagan BG
BMJ Open Gastroenterol; 2024 Feb; 11(1):. PubMed ID: 38336367
[TBL] [Abstract][Full Text] [Related]
19. Predictors of Placebo Induction Response and Remission in Ulcerative Colitis.
Wong ECL; Dulai PS; Marshall JK; Jairath V; Reinisch W; Narula N
Clin Gastroenterol Hepatol; 2023 Apr; 21(4):1050-1060.e9. PubMed ID: 36029969
[TBL] [Abstract][Full Text] [Related]
20. Plasma intestinal fatty acid-binding protein fails to predict endoscopic disease activity in inflammatory bowel disease patients.
Bodelier AG; Pierik MJ; Lenaerts K; de Boer E; Olde Damink SW; Hameeteman WM; Masclee AA; Jonkers DM
Eur J Gastroenterol Hepatol; 2016 Jul; 28(7):807-13. PubMed ID: 26919325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
